Adverse effects: at least one serious adverse event · people in the prodromal stage of psychosis
1 finding from 1 review
Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with non‐directive reflective listening + supportive intervention (very low certainty).
1 finding from 1 review
Depressive symptoms · depression and anxiety for people with dementia and MCI
CBT treatments showed no clear difference in depressive symptoms post‐treatment compared with treatment (moderate certainty).
1 finding from 1 review
Depression remission · depression and anxiety for people with dementia and MCI
CBT treatments may leads to higher depression remission post‐treatment compared with treatment (low certainty).
1 finding from 1 review
Anxiety · depression and anxiety for people with dementia and MCI
It is very uncertain whether CBT treatments changes anxiety symptoms post‐treatment compared with treatment (very low certainty).
1 finding from 1 review
Quality of life post‐treatment · depression and anxiety for people with dementia and MCI
CBT treatments showed no clear difference in quality of life post‐treatment compared with treatment (moderate certainty).
1 finding from 1 review
Activities of daily living · depression and anxiety for people with dementia and MCI
CBT treatments showed no clear difference in activities of daily living post‐treatment compared with treatment (moderate certainty).
1 finding from 1 review
Cognitive function · depression and anxiety for people with dementia and MCI
CBT treatments showed no clear difference in cognition post‐treatment compared with treatment (low certainty).
1 finding from 1 review
Neuropsychiatric symptoms · depression and anxiety for people with dementia and MCI
It is very uncertain whether CBT treatments changes neuropsychiatric symptoms post‐treatment compared with treatment (very low certainty).
1 finding from 1 review
Depression score · co‐occurring depression and substance use disorders
2 findings from 1 review
Percent of days abstinent · co‐occurring depression and substance use disorders
2 findings from 1 review
Retention in treatment · co‐occurring depression and substance use disorders
It is very uncertain whether integrated CBT changes treatment retention compared with twelve Step Facilitation (very low certainty).
1 finding from 1 review
Number of treatment sessions attended Scale from: 0 to 36 · co‐occurring depression and substance use disorders
1 finding from 1 review
Clinical non‐response at post‐treatment · depression
It is very uncertain whether third wave CBT changes clinical non‐response at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Acceptability (number of participants lost to post‐treatment assessment) · depression
It is very uncertain whether third wave CBT changes treatment acceptability (dropout) at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Clinical non‐remission at post‐treatment · depression
It is very uncertain whether third wave CBT changes clinical non‐remission at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Depression levels at post‐treatment · depression
1 finding from 1 review
Anxiety · depression
1 finding from 1 review
Social adjustment levels at post‐treatment— behavioural activation vs TAU Work and Social Ajustment Scale (WSAS) · depression
1 finding from 1 review